{"id":"https://openalex.org/W3083468942","doi":"https://doi.org/10.1158/1538-7445.am2020-lb-094","title":"Abstract LB-094: Hepavac-101 first-in-man clinical trial of a multi-peptide-based vaccine for hepatocellular carcinoma","display_name":"Abstract LB-094: Hepavac-101 first-in-man clinical trial of a multi-peptide-based vaccine for hepatocellular carcinoma","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083468942","doi":"https://doi.org/10.1158/1538-7445.am2020-lb-094","mag":"3083468942"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-lb-094","doi":"https://doi.org/10.1158/1538-7445.am2020-lb-094","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-lb-094","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027662125","display_name":"Luigi Buonaguro","orcid":"https://orcid.org/0000-0002-6380-7114","observed_orcids":["https://orcid.org/0000-0002-6380-7114","https://orcid.org/0000-0002-7491-7220"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Luigi Buonaguro","raw_affiliation_strings":["1ISTITUTO NAZIONALE TUMORI IRCCS - Fondazione Pascale, NAPLES, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ISTITUTO NAZIONALE TUMORI IRCCS - Fondazione Pascale, NAPLES, Italy;","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110145053","display_name":"A Mayer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andrea Mayer","raw_affiliation_strings":["2Immatics Biotechnologies GmbH, Tuebingen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Immatics Biotechnologies GmbH, Tuebingen, Germany;","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112582631","display_name":"Markus W. Loeffler","orcid":"https://orcid.org/0000-0003-2513-1317","observed_orcids":["https://orcid.org/0000-0003-2513-1317"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Markus Loeffler","raw_affiliation_strings":["3Eberhard Karls University, Tuebingen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Eberhard Karls University, Tuebingen, Germany;","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089906093","display_name":"Sarah Missel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sarah Missel","raw_affiliation_strings":["2Immatics Biotechnologies GmbH, Tuebingen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Immatics Biotechnologies GmbH, Tuebingen, Germany;","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084091903","display_name":"Roberto Sergio Accolla","orcid":"https://orcid.org/0000-0003-2493-7378","observed_orcids":["https://orcid.org/0000-0003-2493-7378"]},"institutions":[{"id":"https://openalex.org/I115752224","display_name":"University of Insubria","ror":"https://ror.org/00s409261","country_code":"IT","type":"education","lineage":["https://openalex.org/I115752224"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Roberto Accolla","raw_affiliation_strings":["4University of Insubria, Medicine and Surgery, Varese, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4University of Insubria, Medicine and Surgery, Varese, Italy;","institution_ids":["https://openalex.org/I115752224"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063557693","display_name":"Yuk Ting Ma","orcid":"https://orcid.org/0000-0001-7830-6091","observed_orcids":["https://orcid.org/0000-0001-7830-6091"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Yuk Ting Ma","raw_affiliation_strings":["5University of Birmingham, Birmingham, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5University of Birmingham, Birmingham, United Kingdom;","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072158103","display_name":"Tanguy Chaumette","orcid":"https://orcid.org/0000-0002-5830-8767","observed_orcids":["https://orcid.org/0000-0002-5830-8767"]},"institutions":[{"id":"https://openalex.org/I4405260337","display_name":"Universit\u00e9 de Nantes","ror":"https://ror.org/03kjmz544","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405260337","https://openalex.org/I97188460"]},{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Tanguy Chaumette","raw_affiliation_strings":["6University of Nantes, NANTES, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6University of Nantes, NANTES, France;","institution_ids":["https://openalex.org/I4405260337","https://openalex.org/I97188460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039481797","display_name":"Regina Heidenreich","orcid":"https://orcid.org/0000-0002-8607-9412","observed_orcids":["https://orcid.org/0000-0002-8607-9412"]},"institutions":[{"id":"https://openalex.org/I4210123470","display_name":"CureVac (Germany)","ror":"https://ror.org/02q3n2241","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210123470"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Regina Heidenreich","raw_affiliation_strings":["7CureVac AG, Tuebingen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7CureVac AG, Tuebingen, Germany;","institution_ids":["https://openalex.org/I4210123470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009336896","display_name":"Alfred K\u00f6nigsrainer","orcid":"https://orcid.org/0000-0002-2301-4080","observed_orcids":["https://orcid.org/0000-0002-2301-4080"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Alfred K\u00f6nigsrainer","raw_affiliation_strings":["3Eberhard Karls University, Tuebingen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Eberhard Karls University, Tuebingen, Germany;","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075824270","display_name":"Joerg Ludwig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Joerg Ludwig","raw_affiliation_strings":["2Immatics Biotechnologies GmbH, Tuebingen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Immatics Biotechnologies GmbH, Tuebingen, Germany;","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060229531","display_name":"Diego Duarte Alcoba","orcid":"https://orcid.org/0000-0003-0702-6994","observed_orcids":["https://orcid.org/0000-0003-0702-6994"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Diego Alcoba","raw_affiliation_strings":["2Immatics Biotechnologies GmbH, Tuebingen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Immatics Biotechnologies GmbH, Tuebingen, Germany;","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088860072","display_name":"Heiko Schuster","orcid":"https://orcid.org/0009-0002-6446-9425","observed_orcids":["https://orcid.org/0009-0002-6446-9425"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Heiko Schuster","raw_affiliation_strings":["2Immatics Biotechnologies GmbH, Tuebingen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Immatics Biotechnologies GmbH, Tuebingen, Germany;","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036345079","display_name":"Cecile Gouttenfangeas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Cecile Gouttenfangeas","raw_affiliation_strings":["3Eberhard Karls University, Tuebingen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Eberhard Karls University, Tuebingen, Germany;","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020886709","display_name":"Greta Forlani","orcid":"https://orcid.org/0000-0003-1987-7761","observed_orcids":["https://orcid.org/0000-0003-1987-7761"]},"institutions":[{"id":"https://openalex.org/I115752224","display_name":"University of Insubria","ror":"https://ror.org/00s409261","country_code":"IT","type":"education","lineage":["https://openalex.org/I115752224"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Greta Forlani","raw_affiliation_strings":["4University of Insubria, Medicine and Surgery, Varese, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4University of Insubria, Medicine and Surgery, Varese, Italy;","institution_ids":["https://openalex.org/I115752224"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076878292","display_name":"Maria Tagliamonte","orcid":"https://orcid.org/0000-0002-7167-4817","observed_orcids":["https://orcid.org/0000-0002-7167-4817"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Tagliamonte","raw_affiliation_strings":["1ISTITUTO NAZIONALE TUMORI IRCCS - Fondazione Pascale, NAPLES, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ISTITUTO NAZIONALE TUMORI IRCCS - Fondazione Pascale, NAPLES, Italy;","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029398339","display_name":"Paolo A. Ascierto","orcid":"https://orcid.org/0000-0002-8322-475X","observed_orcids":["https://orcid.org/0000-0002-8322-475X"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Paolo A. Ascierto","raw_affiliation_strings":["1ISTITUTO NAZIONALE TUMORI IRCCS - Fondazione Pascale, NAPLES, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ISTITUTO NAZIONALE TUMORI IRCCS - Fondazione Pascale, NAPLES, Italy;","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088304855","display_name":"Antonio Avallone","orcid":"https://orcid.org/0000-0001-6188-5664","observed_orcids":["https://orcid.org/0000-0001-6188-5664"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Antonio Avallone","raw_affiliation_strings":["1ISTITUTO NAZIONALE TUMORI IRCCS - Fondazione Pascale, NAPLES, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ISTITUTO NAZIONALE TUMORI IRCCS - Fondazione Pascale, NAPLES, Italy;","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045703385","display_name":"Marco Borrelli","orcid":"https://orcid.org/0000-0003-4226-1340","observed_orcids":["https://orcid.org/0000-0003-4226-1340"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco Borrelli","raw_affiliation_strings":["1ISTITUTO NAZIONALE TUMORI IRCCS - Fondazione Pascale, NAPLES, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1ISTITUTO NAZIONALE TUMORI IRCCS - Fondazione Pascale, NAPLES, Italy;","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090153362","display_name":"Hans\u2010Georg Rammensee","orcid":"https://orcid.org/0000-0003-1614-2647","observed_orcids":["https://orcid.org/0000-0003-1614-2647"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hans-Georg Rammensee","raw_affiliation_strings":["3Eberhard Karls University, Tuebingen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Eberhard Karls University, Tuebingen, Germany;","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085766415","display_name":"Bruno Sangro","orcid":"https://orcid.org/0000-0002-4177-6417","observed_orcids":["https://orcid.org/0000-0002-4177-6417"]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Bruno Sangro","raw_affiliation_strings":["8Clinica Universidad of Navarra, PAMPLONA, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Clinica Universidad of Navarra, PAMPLONA, Spain;","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043869708","display_name":"Mercedes I\u00f1arrairaegui","orcid":"https://orcid.org/0000-0001-9180-4693","observed_orcids":["https://orcid.org/0000-0001-9180-4693"]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mercedes I\u00f1arrairaegui","raw_affiliation_strings":["8Clinica Universidad of Navarra, PAMPLONA, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Clinica Universidad of Navarra, PAMPLONA, Spain;","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070970519","display_name":"Sven Francque","orcid":"https://orcid.org/0000-0002-7527-4714","observed_orcids":["https://orcid.org/0000-0002-7527-4714"]},"institutions":[{"id":"https://openalex.org/I4210102047","display_name":"Antwerp University Hospital","ror":"https://ror.org/01hwamj44","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210102047"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Sven Francque","raw_affiliation_strings":["9University Hospital Antwerp, ANTWERP, Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9University Hospital Antwerp, ANTWERP, Netherlands;","institution_ids":["https://openalex.org/I4210102047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090419945","display_name":"Luisa Vonghia","orcid":"https://orcid.org/0000-0002-3999-9259","observed_orcids":["https://orcid.org/0000-0002-3999-9259"]},"institutions":[{"id":"https://openalex.org/I4210102047","display_name":"Antwerp University Hospital","ror":"https://ror.org/01hwamj44","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210102047"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Luisa Vonghia","raw_affiliation_strings":["9University Hospital Antwerp, ANTWERP, Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9University Hospital Antwerp, ANTWERP, Netherlands;","institution_ids":["https://openalex.org/I4210102047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022206145","display_name":"Stefania Gori","orcid":"https://orcid.org/0000-0001-6320-405X","observed_orcids":["https://orcid.org/0000-0001-6320-405X"]},"institutions":[{"id":"https://openalex.org/I4210101944","display_name":"Ospedale Sacro Cuore Don Calabria","ror":"https://ror.org/010hq5p48","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210101944"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Stefania Gori","raw_affiliation_strings":["10Ospedale Sacro Cuore - Don G. Calabria, NEGRAR, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Ospedale Sacro Cuore - Don G. Calabria, NEGRAR, Italy;","institution_ids":["https://openalex.org/I4210101944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085265624","display_name":"Toni Weinschenk","orcid":"https://orcid.org/0000-0001-8644-0290","observed_orcids":["https://orcid.org/0000-0001-8644-0290"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Tony Weinschenk","raw_affiliation_strings":["11Immatics Biotechnologies GmbH, Tuebingen, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Immatics Biotechnologies GmbH, Tuebingen, TX","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030980984","display_name":"Carsten Reinhardt","orcid":"https://orcid.org/0000-0003-2905-1920","observed_orcids":["https://orcid.org/0000-0003-2905-1920"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Carsten Reinhardt","raw_affiliation_strings":["2Immatics Biotechnologies GmbH, Tuebingen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Immatics Biotechnologies GmbH, Tuebingen, Germany;","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054698965","display_name":"Ulrike Gnad-Vogt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123470","display_name":"CureVac (Germany)","ror":"https://ror.org/02q3n2241","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210123470"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ulrike Gnad-Vogt","raw_affiliation_strings":["7CureVac AG, Tuebingen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7CureVac AG, Tuebingen, Germany;","institution_ids":["https://openalex.org/I4210123470"]}]},{"author_position":"last","author":{"id":null,"display_name":"Harpreet Singh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Harpreet Singh","raw_affiliation_strings":["11Immatics Biotechnologies GmbH, Tuebingen, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Immatics Biotechnologies GmbH, Tuebingen, TX","institution_ids":["https://openalex.org/I4210138096"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"LB","last_page":"094"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.01759999990463257,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9810000061988831},{"id":"https://openalex.org/keywords/cancer-vaccines","display_name":"cancer vaccines","score":0.6159999966621399},{"id":"https://openalex.org/keywords/multipeptide-vaccine","display_name":"multipeptide vaccine","score":0.8529999852180481},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.7059999704360962},{"id":"https://openalex.org/keywords/hla-a-02","display_name":"HLA-A*02","score":0.7879999876022339},{"id":"https://openalex.org/keywords/hla-a24","display_name":"HLA-A24","score":0.9940000176429749},{"id":"https://openalex.org/keywords/tumor-associated-peptides","display_name":"tumor-associated peptides","score":0.4779999852180481},{"id":"https://openalex.org/keywords/vaccine-safety-and-tolerability","display_name":"vaccine safety and tolerability","score":0.6779999732971191},{"id":"https://openalex.org/keywords/antigen-specific-t-cell-responses","display_name":"antigen-specific T cell responses","score":0.9169999957084656},{"id":"https://openalex.org/keywords/tumor-infiltrating-t-cells","display_name":"tumor-infiltrating T cells","score":0.7919999957084656}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8494758009910583},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6572448015213013},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6059589385986328},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.5949912071228027},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.574131965637207},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5462162494659424},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.542549192905426},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.53956538438797},{"id":"https://openalex.org/C2778378633","wikidata":"https://www.wikidata.org/wiki/Q2378309","display_name":"Cancer vaccine","level":4,"score":0.5096771717071533},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5095698833465576},{"id":"https://openalex.org/C2776789287","wikidata":"https://www.wikidata.org/wiki/Q7166532","display_name":"Peptide vaccine","level":4,"score":0.4815857410430908},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4722430408000946},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.4499160945415497},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33886465430259705},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.29630815982818604},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.22018030285835266},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.11010831594467163}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-lb-094","doi":"https://doi.org/10.1158/1538-7445.am2020-lb-094","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-lb-094","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4224036571","https://openalex.org/W2889627310","https://openalex.org/W2797693513","https://openalex.org/W2548672098","https://openalex.org/W601898829","https://openalex.org/W4256187616","https://openalex.org/W2613977705","https://openalex.org/W4327676495","https://openalex.org/W1972437169","https://openalex.org/W2478299622"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"and":[2,95,106,143,185,210,232,237,255,263,325,448],"Aims:":[3],"Hepatocellular":[4],"carcinoma":[5,429],"(HCC)":[6],"is":[7,46,65,121,339],"the":[8,79,116,203,299,318,332,340,343,348,434,438],"third":[9],"leading":[10],"cause":[11],"of":[12,158,167,178,183,196,202,268,331,342,423,433,437],"death":[13],"from":[14,108],"cancer":[15,57],"globally":[16],"with":[17,78,139,153,193,301,310,354],"an":[18,85,172],"extremely":[19],"variable":[20],"5-year":[21],"survival":[22,236],"rate.":[23],"Immunotherapy":[24],"strategies":[25],"for":[26,284,427,441],"HCC":[27,39,111,279],"may":[28],"represent":[29],"a":[30,47,55,66,73,122,131,163,306,424],"key":[31],"therapeutic":[32,56],"tool":[33],"to":[34,150],"improve":[35],"clinical":[36,52,205,337,421],"outcome":[37],"in":[38,59,222,226,230,244,248],"patients.":[40],"HepaVac-101":[41,204],"(EudraCT":[42],"Number:":[43],"2015-003389-10;":[44],"NCT03203005),":[45],"single-arm,":[48],"first-in-man":[49,420],"Phase":[50],"I/II":[51],"trial":[53,206,269,338,422],"evaluating":[54],"vaccine":[58,75,91,426],"patients":[60,138,280,289],"affected":[61],"by":[62,114,347],"HCC.":[63],"It":[64],"highly":[67],"innovative,":[68],"novel":[69,123],"approach":[70],"based":[71,127],"on":[72,273,292],"multi-peptide":[74],"(IMA970A)":[76],"combined":[77],"TLR7/8/RIG":[80],"I":[81],"agonist":[82],"CV8102":[83,120,161],"as":[84,98,100,171],"adjuvant.":[86],"Method:":[87],"The":[88,199,266,303,335],"IMA970A":[89,159],"off-the-shelf":[90],"includes":[92],"5":[93,249],"HLA-A*24":[94],"7":[96],"HLA-A*02":[97],"well":[99],"4":[101],"HLA-DR":[102],"restricted":[103],"peptides":[104],"identified":[105],"selected":[107],"native":[109],"human":[110],"tumor":[112,227],"tissue":[113],"applying":[115],"XPRESIDENT\u00ae":[117],"discovery":[118],"platform.":[119],"ribonucleic":[124],"acid":[125],"(RNA)":[126],"immunostimulatory":[128],"agent":[129],"inducing":[130],"balanced":[132],"Th1/Th2":[133],"immune":[134],"response.HLA-A*02":[135],"and/or":[136],"A*24-positive":[137],"very":[140],"early,":[141],"early":[142],"intermediate":[144],"stage":[145],"HCCs":[146],"have":[147,175,281],"been":[148,282],"enrolled":[149,243],"be":[151,327],"treated":[152],"9":[154],"intradermal":[155],"vaccinations":[156],"consisting":[157],"plus":[160],"following":[162],"single":[164],"pre-vaccination":[165],"infusion":[166],"low-dose":[168],"cyclophosphamide":[169],"acting":[170],"immunomodulator.":[173],"Patients":[174,241],"completed":[176],"standard":[177],"care":[179],"treatments":[180],"at":[181,297,329],"time":[182,330],"enrolment":[184],"received":[186,296],"study":[187,293],"drugs":[188],"without":[189],"concomitant":[190],"anti-tumor":[191],"therapy":[192],"no":[194,311],"evidence":[195],"disease":[197],"reactivation.":[198],"primary":[200],"endpoints":[201,217],"are":[207,218,322],"safety,":[208],"tolerability,":[209],"antigen":[211],"specific":[212],"T":[213],"cell":[214],"response.":[215],"Secondary/exploratory":[216],"additional":[219],"immunological":[220],"parameters":[221],"blood,":[223],"infiltrating":[224],"T-lymphocytes":[225],"tissue,":[228,233],"biomarkers":[229],"blood":[231],"disease-free":[234],"survival/progression-free":[235],"overall":[238],"survival.":[239],"Results:":[240],"were":[242,290],"6":[245],"centers":[246],"located":[247],"European":[250,349],"countries":[251],"i.e.":[252],"Italy":[253],"(Naples":[254],"Negrar/Varese),":[256],"Germany":[257],"(T\u00fcbingen),":[258],"UK":[259],"(Birmingham),":[260],"Spain":[261],"(Pamplona)":[262],"Belgium":[264],"(Antwerp).":[265],"end":[267],"(EOT)":[270],"was":[271],"reached":[272],"last":[274],"December":[275],"20,":[276],"2019.":[277],"82":[278],"screened":[283],"suitable":[285],"HLA":[286],"haplotypes,":[287],"22":[288],"put":[291],"treatment":[294],"(i.e.":[295],"least":[298],"pre-treatment":[300],"cyclophosphamide).":[302],"vaccination":[304],"showed":[305],"good":[307],"safety":[308],"profile":[309],"major":[312],"SAE":[313],"nor":[314],"AESI":[315],"reported":[316],"during":[317],"protocol.":[319],"Immunogenicity":[320],"data":[321],"currently":[323],"evaluated":[324],"will":[326],"available":[328],"meeting.":[333],"Conclusion:":[334],"HEPAVAC-101":[336],"achievement":[341],"HEPAVAC":[344],"Consortium":[345],"supported":[346],"Commission's":[350],"7th":[351],"framework":[352],"program":[353],"contract":[355],"No.":[356],"602893":[357],"(www.hepavac.eu).":[358],"Citation":[359],"Format:":[360],"Luigi":[361],"Buonaguro,":[362],"Andrea":[363],"Mayer,":[364],"Markus":[365],"Loeffler,":[366],"Sarah":[367],"Missel,":[368],"Roberto":[369],"Accolla,":[370],"Yuk":[371],"Ting":[372],"Ma,":[373],"Tanguy":[374],"Chaumette,":[375],"Regina":[376],"Heidenreich,":[377],"Alfred":[378],"K\u00f6nigsrainer,":[379],"Joerg":[380],"Ludwig,":[381],"Diego":[382],"Alcoba,":[383],"Heiko":[384],"Schuster,":[385],"Cecile":[386],"Gouttenfangeas,":[387],"Greta":[388],"Forlani,":[389],"Maria":[390],"Tagliamonte,":[391],"Paolo":[392],"A.":[393],"Ascierto,":[394],"Antonio":[395],"Avallone,":[396],"Marco":[397],"Borrelli,":[398],"Hans-Georg":[399],"Rammensee,":[400],"Bruno":[401],"Sangro,":[402],"Mercedes":[403],"I\u00f1arrairaegui,":[404],"Sven":[405],"Francque,":[406],"Luisa":[407],"Vonghia,":[408],"Stefania":[409],"Gori,":[410],"Tony":[411],"Weinschenk,":[412],"Carsten":[413],"Reinhardt,":[414],"Ulrike":[415],"Gnad-Vogt,":[416],"Harpreet":[417],"Singh.":[418],"Hepavac-101":[419],"multi-peptide-based":[425],"hepatocellular":[428],"[abstract].":[430],"In:":[431],"Proceedings":[432],"Annual":[435],"Meeting":[436],"American":[439],"Association":[440],"Cancer":[442,454],"Research":[443],"2020;":[444],"2020":[445],"Apr":[446],"27-28":[447],"Jun":[449],"22-24.":[450],"Philadelphia":[451],"(PA):":[452],"AACR;":[453],"Res":[455],"2020;80(16":[456],"Suppl):Abstract":[457],"nr":[458],"LB-094.":[459]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2020-09-11T00:00:00"}